BioCorRx (BICX) Net Income towards Common Stockholders (2010 - 2026)
BioCorRx (BICX) posted Net Income towards Common Stockholders of -$859892.0 for Q1 2026, down 83.58% sequentially from -$468391.0 in Q4 2025, and down 0.95% YoY from -$868176.6 in Q1 2025.
BioCorRx (BICX) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
BioCorRx has reported Net Income towards Common Stockholders for 17 years, with the latest figure at -$859892.0 in Q1 2026.
- Quarterly Net Income towards Common Stockholders fell 0.95% year-over-year to -$859892.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.7 million (up 43.88% YoY) and the FY2025 annual result came in at -$3.5 million, up 31.28% from the prior year.
- Net Income towards Common Stockholders eased to -$859892.0 in Q1 2026 per BICX's latest filing, from -$468391.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$2830.0 in Q3 2025 and troughed at -$1.5 million in Q3 2024.
- A 5-year average of -$995133.5 and a median of -$969009.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders tumbled 74.44% in 2024, then jumped 99.81% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$1.2 million in 2022, then advanced by 16.68% to -$969009.0 in 2023, then dropped by 26.69% to -$1.2 million in 2024, then soared by 61.85% to -$468391.0 in 2025, then sank by 83.58% to -$859892.0 in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$859892.0, -$468391.0, and -$2830.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 1.93 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 826.00 Mn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -600,000.00 |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 343.22 Mn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 99.83 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 358.45 Mn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 76.35 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 67.70 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 67.30 Mn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -859,892.00 |
| Dec 31, 2025 | -468,391.00 |
| Sep 30, 2025 | -2,830.00 |
| Jun 30, 2025 | -1.38 Mn |
| Mar 31, 2025 | -851,764.00 |
| Dec 31, 2024 | -1.23 Mn |
| Sep 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -1.24 Mn |
| Dec 31, 2023 | -969,009.00 |
| Sep 30, 2023 | -867,348.00 |
| Jun 30, 2023 | -923,547.00 |
| Mar 31, 2023 | -1.01 Mn |
| Dec 31, 2022 | -1.16 Mn |
| Sep 30, 2022 | -951,006.00 |
| Jun 30, 2022 | -1.32 Mn |
| Mar 31, 2022 | -944,440.00 |
| Dec 31, 2021 | -1.20 Mn |
| Sep 30, 2021 | -1.36 Mn |
| Jun 30, 2021 | -1.06 Mn |